Corporate information
Overview
Deep 6 AI accelerates the clinical trial enrollment process by transforming the way researchers identify eligible patients. Using artificial intelligence and natural language processing to mine structured and unstructured patient data, Deep 6 AI finds more, better-matching patients for trials in minutes, rather than months.
Funding rounds
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
Point72 Ventures LLC | Early-stage venture capital strategy funded exclusively by Steve Cohen and eligible employees of Point72 Asset Management. | Initial investment. |
Investment activity status
Active investor